Capricor Therapeutics Announces Positive Topline Results from Pivotal Phase 3 HOPE-3 Study of Deramiocel in Duchenne Muscular Dystrophy
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 08/09/19 | Statement of changes in beneficial ownership of securities |
|
1 | ||
| 08/09/19 | Statement of changes in beneficial ownership of securities |
|
1 | ||
| 08/09/19 | Statement of changes in beneficial ownership of securities |
|
1 | ||
| 08/09/19 | Statement of changes in beneficial ownership of securities |
|
1 | ||
| 08/08/19 | Quarterly report pursuant to Section 13 or 15(d) |
|
 |
77 | |
| 08/06/19 | Current report filing |
|
8 | ||
| 07/22/19 | Prospectus filed pursuant to Rule 424(b)(5) |
|
60 | ||
| 07/22/19 | Current report filing |
|
29 | ||
| 07/18/19 | Notice of Effectiveness |
|
1 | ||
| 07/17/19 | Registration statement for specified transactions by certain issuers |
|
52 |